Interventricular Septal Thickness and Left Ventricular Hypertrophy
... SUMMARY Septal and left ventricular posterior wall (LVPW) thicknesses and their ratios were studied at the left ventricular outflow tract and left ventricular cavity in 66 patients with echocardiographically diagnosed left ventricular concentric hypertrophy, 20 with idiopathic hypertrophic subaortic ...
... SUMMARY Septal and left ventricular posterior wall (LVPW) thicknesses and their ratios were studied at the left ventricular outflow tract and left ventricular cavity in 66 patients with echocardiographically diagnosed left ventricular concentric hypertrophy, 20 with idiopathic hypertrophic subaortic ...
Interventricular Septal Thickness and Left Ventricular
... SUMMARY Septal and left ventricular posterior wall (LVPW) thicknesses and their ratios were studied at the left ventricular outflow tract and left ventricular cavity in 66 patients with echocardiographically diagnosed left ventricular concentric hypertrophy, 20 with idiopathic hypertrophic subaortic ...
... SUMMARY Septal and left ventricular posterior wall (LVPW) thicknesses and their ratios were studied at the left ventricular outflow tract and left ventricular cavity in 66 patients with echocardiographically diagnosed left ventricular concentric hypertrophy, 20 with idiopathic hypertrophic subaortic ...
Hands-Only CPR Frequently Asked Questions (FAQs)
... Is there a danger in jumping in and giving CPR without being trained? On average, any attempt to provide CPR to a person in cardiac arrest is better than no attempt to provide help. Why did the American Heart Association decide to recommend Hands-Only CPR for adults who suddenly collapse? Every five ...
... Is there a danger in jumping in and giving CPR without being trained? On average, any attempt to provide CPR to a person in cardiac arrest is better than no attempt to provide help. Why did the American Heart Association decide to recommend Hands-Only CPR for adults who suddenly collapse? Every five ...
NIH Public Access - IUPUI ScholarWorks
... extrinsic and intrinsic nervous systems are important for cardiac function and arrhythmogenesis.7–10 The vagal nerves include axons that come from various nuclei in the medulla. The extrinsic sympathetic nerves come from the paravertebral ganglia, including the superior cervical ganglion, middle cer ...
... extrinsic and intrinsic nervous systems are important for cardiac function and arrhythmogenesis.7–10 The vagal nerves include axons that come from various nuclei in the medulla. The extrinsic sympathetic nerves come from the paravertebral ganglia, including the superior cervical ganglion, middle cer ...
Characterization and Modeling of the Purkinje System for Biophysical Simulations
... its branches [7, 58, 100, 148, 167]. To visualize the net structure it is necessary to apply sub-endocardial injections of ink or stains. It is very difficult to observe the Purkinje-net system in humans, because these fibres do not stain well. Ex-vivo histological and microscopy animal data of the ...
... its branches [7, 58, 100, 148, 167]. To visualize the net structure it is necessary to apply sub-endocardial injections of ink or stains. It is very difficult to observe the Purkinje-net system in humans, because these fibres do not stain well. Ex-vivo histological and microscopy animal data of the ...
CARDS Cardiology Audit and Registration Data Standards for
... NB - the variables in this group would be essential components of a minimum core data set and include variables without which the data would be considered useless, e.g. sex, age, diagnosis. These variables include those, which would be essential in order to link up with other cardiovascular disease ...
... NB - the variables in this group would be essential components of a minimum core data set and include variables without which the data would be considered useless, e.g. sex, age, diagnosis. These variables include those, which would be essential in order to link up with other cardiovascular disease ...
Electrocardiography - Tehran Arrhythmia Center
... Other underlying abnormalities Tehran Arrhythmia Center ...
... Other underlying abnormalities Tehran Arrhythmia Center ...
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE
... gradually over a period of 10 – 14 days, in diminishing doses to 25 mg daily for the last 6 days. Abrupt withdrawal may cause an acute aggravation of the patient’s condition, particularly in patients with ischaemic heart disease. Hypertension and arrhythmias may occur. Therefore, these patients must ...
... gradually over a period of 10 – 14 days, in diminishing doses to 25 mg daily for the last 6 days. Abrupt withdrawal may cause an acute aggravation of the patient’s condition, particularly in patients with ischaemic heart disease. Hypertension and arrhythmias may occur. Therefore, these patients must ...
Accuracy of ECG interpretation in competitive athletes: the impact of
... ECG is also commonly obtained in athletes with cardiovascular-related symptoms, concerning medical history or physical examination fi ndings. Whether performed for diagnostic or screening purposes as part of the cardiac evaluation in athletes, quality ECG interpretations are crucial to identify athle ...
... ECG is also commonly obtained in athletes with cardiovascular-related symptoms, concerning medical history or physical examination fi ndings. Whether performed for diagnostic or screening purposes as part of the cardiac evaluation in athletes, quality ECG interpretations are crucial to identify athle ...
Evidence for the Presence of Calsequestrin in Both Peripheral and
... calsequestrin, which appears to be confined to the lumen of the peripheral and interior junctional sarcoplasmic reticulum. Regarding the distribution of calsequestrin, this interpretation predicts that calsequestrin in myocardial cells without transverse tubules would be present in the lumen of the ...
... calsequestrin, which appears to be confined to the lumen of the peripheral and interior junctional sarcoplasmic reticulum. Regarding the distribution of calsequestrin, this interpretation predicts that calsequestrin in myocardial cells without transverse tubules would be present in the lumen of the ...
Several of the cells have drop down menus with them – if you see an
... Pre BiV transplant status (Not listed, 1a,1b,2,7): Listed or not and status in 24 hours prior to BiV placement Duration of Data Collection Period Pre BiV: We would like to review clinical events for a maximum of 1 year prior to biV. In some cases, due to patient age, referral date or onset of diseas ...
... Pre BiV transplant status (Not listed, 1a,1b,2,7): Listed or not and status in 24 hours prior to BiV placement Duration of Data Collection Period Pre BiV: We would like to review clinical events for a maximum of 1 year prior to biV. In some cases, due to patient age, referral date or onset of diseas ...
healthcare professionals should be able to recognise cardiac arrest
... asphyxial arrest. Early recognition and call for help Chest pain should be recognised as a symptom of myocardial ischaemia. Cardiac arrest occurs in a quarter to a third of patients with myocardial ischaemia within the first hour after onset of chest pain. Recognising the cardiac origin of chest pai ...
... asphyxial arrest. Early recognition and call for help Chest pain should be recognised as a symptom of myocardial ischaemia. Cardiac arrest occurs in a quarter to a third of patients with myocardial ischaemia within the first hour after onset of chest pain. Recognising the cardiac origin of chest pai ...
Pacemakers and ICDs-2012 - UCSF Department of Anesthesia and
... been used with AICD, instead of implantable, especially in the non-medical literature. Nowhere in the Content Outline do you see the term cardiac implantable electronic device (CIED). CIED is typically used, refers to any both pacemakers and ICDs, and I will use it throughout this handout. Finally, ...
... been used with AICD, instead of implantable, especially in the non-medical literature. Nowhere in the Content Outline do you see the term cardiac implantable electronic device (CIED). CIED is typically used, refers to any both pacemakers and ICDs, and I will use it throughout this handout. Finally, ...
2014 AHA/ACC/HRS Guideline for the€Management of Patients
... A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a part ...
... A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a part ...
Left-to-Right Shunt Lesions
... shorter connections with larger diameters produce less resistance, i.e. allow greater flow. In patients with large PDAs, the diastolic runoff into the pulmonary artery results in lowered aortic diastolic pressure, which may increase the risk of myocardial ischemia, especially in the presence of anem ...
... shorter connections with larger diameters produce less resistance, i.e. allow greater flow. In patients with large PDAs, the diastolic runoff into the pulmonary artery results in lowered aortic diastolic pressure, which may increase the risk of myocardial ischemia, especially in the presence of anem ...
Full Text - Jentashapir Journal of Health Research
... in the world, suffered death yearly. Epidemiological studies have shown that more than one case out of 10 cases of cardiovascular deaths, which include 54% of all deaths worldwide, is due to cigarettes. Objectives: The current study aimed to evaluate the acute and chronic effects of smoking on the l ...
... in the world, suffered death yearly. Epidemiological studies have shown that more than one case out of 10 cases of cardiovascular deaths, which include 54% of all deaths worldwide, is due to cigarettes. Objectives: The current study aimed to evaluate the acute and chronic effects of smoking on the l ...
2014 AHA/ACC/HRS Guideline for the€Management of
... A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a part ...
... A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a part ...
Arterial Stiffness in the Young: Assessment
... rapidly over the last decade; these include traditional cardiovascular risk factors, prenatal growth restriction, vasculitides, vasculopathies associated with various syndromes, congenital heart disease, and several systemic diseases. The findings of arterial stiffening have functional implications ...
... rapidly over the last decade; these include traditional cardiovascular risk factors, prenatal growth restriction, vasculitides, vasculopathies associated with various syndromes, congenital heart disease, and several systemic diseases. The findings of arterial stiffening have functional implications ...
Steeper restitution slopes across right ventricular endocardium in
... restitution slopes across right ventricular endocardium in patients with cardiomyopathy at high risk of ventricular arrhythmias. Am J Physiol Heart Circ Physiol 292: H1262–H1268, 2007. First published November 10, 2006; doi:10.1152/ajpheart.00913.2006.—Steep action potential duration (APD) restituti ...
... restitution slopes across right ventricular endocardium in patients with cardiomyopathy at high risk of ventricular arrhythmias. Am J Physiol Heart Circ Physiol 292: H1262–H1268, 2007. First published November 10, 2006; doi:10.1152/ajpheart.00913.2006.—Steep action potential duration (APD) restituti ...
EMBLEMTM S-ICD System Patient Handbook
... When is this device used? Your doctor has decided that you should receive a defibrillator because you have an increased risk of sudden cardiac death due to ventricular rhythm disturbances, and you do not have other types of arrhythmias that would be more appropriately treated with a pacemaker or oth ...
... When is this device used? Your doctor has decided that you should receive a defibrillator because you have an increased risk of sudden cardiac death due to ventricular rhythm disturbances, and you do not have other types of arrhythmias that would be more appropriately treated with a pacemaker or oth ...
Ninth nuclear cardiology invitational conference, Annapolis
... severity of coronary atherosclerosis, none of them identify patients with active disease and who are at risk of plaque rupture. Consequently, approaches to image the vascular wall are desperately needed to improve understanding of the pathobiology of atherosclerosis, to better risk stratify patients ...
... severity of coronary atherosclerosis, none of them identify patients with active disease and who are at risk of plaque rupture. Consequently, approaches to image the vascular wall are desperately needed to improve understanding of the pathobiology of atherosclerosis, to better risk stratify patients ...
Myocardial infarction
Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack, occurs when blood flow stops to a part of the heart causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Often it is in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like heartburn. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or feeling tired. About 30% of people have atypical symptoms, with women more likely than men to present atypically. Among those over 75 years old, about 5% have had an MI with little or no history of symptoms. An MI may cause heart failure, an irregular heartbeat, or cardiac arrest.Most MIs occur due to coronary artery disease. Risk factors include high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol intake, among others. The mechanism of an MI often involves the rupture of an atherosclerotic plaque, leading to complete blockage of a coronary artery. MIs are less commonly caused by coronary artery spasms, which may be due to cocaine, significant emotional stress, and extreme cold, among others. A number of tests are useful to help with diagnosis, including electrocardiograms (ECGs), blood tests, and coronary angiography. An ECG may confirm an ST elevation MI if ST elevation is present. Commonly used blood tests include troponin and less often creatine kinase MB.Aspirin is an appropriate immediate treatment for a suspected MI. Nitroglycerin or opioids may be used to help with chest pain; however, they do not improve overall outcomes. Supplemental oxygen should be used in those with low oxygen levels or shortness of breath. In ST elevation MIs treatments which attempt to restore blood flow to the heart are typically recommended and include angioplasty, where the arteries are pushed open, or thrombolysis, where the blockage is removed using medications. People who have a non-ST elevation myocardial infarction (NSTEMI) are often managed with the blood thinner heparin, with the additional use angioplasty in those at high risk. In people with blockages of multiple coronary arteries and diabetes, bypass surgery (CABG) may be recommended rather than angioplasty. After an MI, lifestyle modifications, along with long term treatment with aspirin, beta blockers, and statins, are typically recommended.Worldwide, more than 3 million people have ST elevation MIs and 4 million have NSTEMIs each year. STEMIs occur about twice as often in men as women. About one million people have an MI each year in the United States. In the developed world the risk of death in those who have had an STEMI is about 10%. Rates of MI for a given age have decreased globally between 1990 and 2010.